Data (n 75) | |
---|---|
Age at surgery [mean (SD)] (y) | 40.4 (7.6) |
Male [n (%)] | 34 (45.3%) |
Race [n (%)] | |
White | 59 (78.7%) |
African American | 5 (6.7%) |
Hispanic | 10 (13.3%) |
Asian American | 0 (0.0%) |
Other | 1 (1.3%) |
Smoking status | |
Never | 34 (45.3%) |
Former | 17 (22.7%) |
Current | 24 (32.0%) |
Body mass index [mean (SD)] (kg/m2) | 27.3 (4.4) |
ODI score [mean (SD)] (out of 100) | 62.7 (10.3) |
Narcotic use as prior treatment [n (%)] | 57 (76.0%) |
Engaged in recreational activity [n (%)] | 37 (49.3%) |
Implant level [n (%)] | |
L3-L4 | 3 (4.0%) |
L4-L5 | 22 (29.3%) |
L5-S1 | 50 (66.7%) |
Prior surgical treatment [n (%)] | 23 (30.7%) |
NOTE. Continuous and ordinal variables were analyzed by a Wilcoxon rank sum test; categorical variables were analyzed with the Fisher exact test to compare Fusion single level Randomized patients (F1R) with Pro- Disc-L single level Randomized patients (P1R).